Biomaterial-based scaffolds are important cues in tissue engineering (TE) applications. Recent advances in TE have led to the development of suitable scaffold architecture for various tissue defects. In this narrative review on polycaprolactone (PCL), we have discussed in detail about the synthesis of PCL, various properties and most recent advances of using PCL and PCL blended with either natural or synthetic polymers and ceramic materials for TE applications. Further, various forms of PCL scaffolds such as porous, films and fibrous have been discussed along with the stem cells and their sources employed in various tissue repair strategies. Overall, the present review affords an insight into the properties and applications of PCL in various tissue engineering applications.

The objective of this work was to investigate material properties and osteogenic differentiation of human mesenchymal stem cells (hMSCs) in genipin (GN) crosslinked chitosan/nano β-tricalcium phosphate (CS/nano β-TCP) scaffolds, and compare the results with tripolyphosphate (TPP) crosslinked scaffolds. Porous crosslinked CS/nano β-TCP scaffolds were produced by freeze-gelation using GN (CBG scaffold) and TPP (CBT scaffold) as crosslinkers. The prepared CBT and CBG scaffolds were characterized with respect to porosity, pore size, water content, wettability, compressive strength, mass loss, and osteogenic differentiation of hMSCs. All scaffolds displayed interconnected honeycomb-like microstructures. There was a significant difference between the average pore size, porosity, contact angle, and percent swelling of CBT and CBG scaffolds. The average pore size of CBG scaffolds was higher than CBT, the porosity of CBG was lower than CBT, the water contact angle of CBG was higher than CBT, and the percent swelling of CBG was lower than CBT. At a given crosslinker concentration, there was not a significant difference in compressive modulus and mass loss of CBG and CBT scaffolds. Metabolic activity of hMSCs seeded in CBG scaffolds was slightly higher than CBT. Furthermore, CBG scaffolds displayed slightly higher extent of mineralization after 21 days incubation in osteogenic medium compared to CBT.

No abstract

Tissue engineering holds an exciting promise in providing a long‐term cure to bone‐related defects and diseases. However, one of the most important prerequisites for bone tissue engineering is an ideal platform that can aid tissue genesis by having biomimetic, mechanostable, and cytocompatible characteristics. Chitosan (CS) was chosen as the base polymer to incorporate filler, namely beta‐tri calcium phosphate (β‐TCP). This research deals with a comparative study on the properties of CS scaffolds prepared using micro‐ and nano‐sized β‐TCP as filler by freeze gelation method. The scaffolds were characterized for their morphology, porosity, swelling, structural, chemical, biodegradation, and bioresorption properties. Rheological behavior of polymer and polymer‐ceramic composite suspensions were analyzed and all the suspensions with varying ratios of β‐TCP showed non‐Newtonian behavior with shear thinning property. Pore size, porosity of micro‐ and nano‐sized composite scaffolds are measured as 48–158 μm and 77% and 43–155 μm and 81%, respectively. The scaffolds containing nano β‐TCP possess higher compressive strength (∼2.67 MPa) and slower degradation rate as compared to composites prepared with micro‐sized β‐TCP (∼1.52 MPa). Bioresorbability, in vitro cell viability by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay, proliferation by Alamar blue assay, cell interaction by scanning electron microscope, and florescence microscopy further validates the potentiality of freeze‐gelled CS/β‐TCP composite scaffolds for bone tissue engineering applications. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 41025.

In the present study, an attempt has been made to improve cell supportive property of chitosan/nano beta tri-calcium phosphate (b-TCP) composite scaffolds by modification of scaffold surface with fibrin using ethyl-3-(3-dimethylaminopropyl) carbodimide (EDC) as crosslinking agent. The developed fibrin conjugated chitosan/nano b-TCP composite scaffolds possess desired pore size and porosity in the range of 45-151 mm and 81.4 6 4.1%, respectively. No significant change in compressive strength of scaffolds was observed before and after fibrin conjugation. The calculated compressive strength of fibrin conjugated and non-conjugated chitosan/nano b-TCP scaffolds are 2.71 6 0.14 MPa and 2.67 6 0.11 MPa, respectively. Results of cell culture study have further shown an enhanced cell attachment, cell number, proliferation, differentiation, and mineralization on fibrin conjugated chitosan/nano b-TCP scaffold. The uniform cell distribution over the scaffold surface and cell infiltration into the scaffold pores were assessed by confocal laser scanning microscopy. Furthermore, higher expression of osteogenic specific genes such as bone sialo protein, osteonectin, alkaline phosphatase, and osteocalcin (OC) on fibrin conjugated scaffolds was observed when compared to scaffolds without fibrin. Altogether, results indicate the potentiality of developed fibrin conjugated composite scaffolds for bone tissue engineering applications.